Treatment of Early Pregnancy Loss With Mifepristone and Misoprostol Compared With Misoprostol Only

米索前列醇 米非司酮 医学 产科 概念产品 流产 早孕损失 怀孕 优势比 流产 妇科 内科学 遗传学 生物
作者
Matan Friedman,Liat Mor,Rotem Shazar,N. L. M. Paul,Ram Kerner,Ran Keidar,Ron Sagiv,Ohad Gluck
出处
期刊:Obstetrics & Gynecology [Lippincott Williams & Wilkins]
被引量:1
标识
DOI:10.1097/aog.0000000000005800
摘要

OBJECTIVE: To compare the rates of treatment failure in cases of early pregnancy loss between mifepristone–misoprostol and misoprostol only. METHODS: This retrospective cohort study included patients who received medical treatment for early pregnancy loss between 2016 and 2023 at a single medical center. Patients returned for a follow-up ultrasonogram after 1 week and were treated again with misoprostol if needed. Finally, they were instructed to obtain an ultrasonogram after menstruation and to return for evaluation in case retained product of conception was suspected. We defined treatment failure as needing any surgical intervention because of retained product of conception, including cases when retained product of conception was diagnosed and treated after menstruation. In May 2022, we changed our protocol for treating early pregnancy loss from misoprostol to mifepristone and misoprostol. We compared the failure rate between patients who received mifepristone–misoprostol and those treated with misoprostol only. RESULTS: A total of 999 patients were included: 224 in the mifepristone–misoprostol group and 775 in the misoprostol-only group. The rate of treatment failure was significantly lower in the mifepristone–misoprostol group compared with the misoprostol-only group (17.8% vs 25.1%, P =.002). After multivariant analysis was performed, the use of mifepristone and misoprostol was associated with a reduction of 34% in the odds ratio for treatment failure compared with misoprostol alone (adjusted odds ratio 0.661, 95% CI, 0.44–0.97, P =.038). In addition, prior vaginal delivery was associated with a lower risk for treatment failure, and increasing gestational age (according to ultrasonogram) was correlated with a higher risk for treatment failure. CONCLUSION: The addition of mifepristone to misoprostol was associated with a significantly lower rate of treatment failure, including late surgical intervention for early pregnancy loss, compared with misoprostol alone.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
τ涛发布了新的文献求助10
1秒前
1秒前
生菜发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
葛泽荣完成签到,获得积分10
2秒前
彭于晏应助hhh采纳,获得10
3秒前
幸运星完成签到,获得积分10
4秒前
科研通AI2S应助不是小苦瓜采纳,获得10
4秒前
小伙子完成签到,获得积分0
4秒前
脑洞疼应助Lizhiiiy采纳,获得10
4秒前
卡卡西应助淡淡的雪采纳,获得20
5秒前
迷人的富发布了新的文献求助10
5秒前
5秒前
Motal发布了新的文献求助10
5秒前
共享精神应助meethaha采纳,获得10
6秒前
jim完成签到,获得积分10
6秒前
叹陌完成签到,获得积分20
6秒前
yxh861106完成签到,获得积分10
6秒前
闾丘笑卉发布了新的文献求助10
7秒前
地瓜完成签到,获得积分10
8秒前
西坡万岁发布了新的文献求助10
8秒前
9秒前
从心随缘完成签到 ,获得积分10
10秒前
10秒前
IceT完成签到,获得积分10
10秒前
10秒前
呆萌冰绿完成签到,获得积分10
11秒前
科研通AI2S应助U9A采纳,获得10
12秒前
Motal完成签到,获得积分20
12秒前
13秒前
13秒前
龍龖龘发布了新的文献求助10
14秒前
慕青应助闾丘笑卉采纳,获得10
14秒前
Lucy完成签到,获得积分10
14秒前
hhh发布了新的文献求助10
15秒前
眼睛大莆发布了新的文献求助10
15秒前
jingsihan完成签到,获得积分10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971791
求助须知:如何正确求助?哪些是违规求助? 3516425
关于积分的说明 11182785
捐赠科研通 3251636
什么是DOI,文献DOI怎么找? 1796048
邀请新用户注册赠送积分活动 876216
科研通“疑难数据库(出版商)”最低求助积分说明 805371